2-Bromo-4,5-Dimethoxybenzyl Bromide
|
2-溴-4,5-二甲氧基溴芐
|
53207-00-4
|
NITROSOISONIPECOTICACID
|
阿伐曲泊帕雜質(zhì)A 1-硝基哌啶-4-羧酸
|
6238-69-3
|
1H-Benzimidazole, 2-(1-nitroso-4-piperidinyl)-
|
阿伐曲泊帕雜質(zhì)BN1-亞硝基比拉斯汀
|
2731008-04-9
|
diethyl (4-amino-3-fluorophenyl)methylmalonate
|
氟比洛芬中間體2對(duì)照品
|
78543-08-5
|
2-Naphthalenecarbonitrile, 6-(acetyloxy)-
|
6-氰萘-2-基乙酸酯
|
860363-16-2
|
diethyl (3-fluoro-4-nitrophenyl)methylmalonate
|
氟比洛芬中間體1對(duì)照品
|
78543-06-3
|
Flurbiprofen Related Impurity 1
|
氟比洛芬中間體3對(duì)照品
|
42771-81-3
|
2-octyldecan-1-ol
|
2-辛基癸烷-1-醇
|
45235-48-1
|
Flurbiprofen Related Impurity 2
|
氟比洛芬中間體4對(duì)照品
|
42771-82-4
|
Benzoic acid, 4,4'-[(1Z)-1-oxido-1,2-diazenediyl]bis-
|
(Z)-1,2-雙(4-羧基苯基)二氮烯 1-氧化物
|
115325-88-7
|
2-Naphthalenecarbonyl chloride, 6-(acetyloxy)-
|
6-(氯羰基)萘-2-乙酸酯
|
121714-82-7
|
Benzoic acid, 2-[(aminoiminomethyl)amino]-
|
2-胍基苯甲酸鹽酸鹽
|
1026613-65-9
|
Benzamide, 4-bromo-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-
|
維奈克拉雜質(zhì)3 維奈克拉雜質(zhì)4
|
2180923-65-1
|
Pinaverium Bromide Impurity 6
|
匹維溴銨雜質(zhì)C 匹維溴銨雜質(zhì)6 HCl
|
53330-19-1
|
Azilsartan Impurity 28
|
阿齊沙坦雜質(zhì)II-2
|
1514933-24-4
|
(Z)-Methyl 2-ethoxy-3-((2'-(N'-(ethoxycarbonyloxy)carbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d]iMidazole-4-carboxylate
|
阿齊沙坦中間體II
|
147404-82-8
|
2-Ethoxy-1-[[2'-[[[(ethoxycarbonyl)oxy]amino]iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester
|
阿齊沙坦雜質(zhì)II-1
|
1403474-75-8
|
|
5-溴煙酸
|
20826-04-4
|
Levosimendan Impurity 1
|
左西孟旦雜質(zhì)1(二聚體雜質(zhì))
|
618458-79-0
|
Deoxycholic Impurity 15
|
脫氧膽酸雜質(zhì)15
|
570-62-7
|
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, ethyl ester
|
非奈利酮雜質(zhì)10
|
2764833-07-8
|
Deoxycholic Impurity 3
|
脫氧膽酸雜質(zhì)3
|
24637-46-5
|
Deoxycholic Impurity 21
|
脫氧膽酸雜質(zhì)21
|
69519-35-3
|
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine
|
匹維溴銨雜質(zhì)A 匹維溴銨雜質(zhì)19
|
77661-66-6
|
6-Quinolinecarboxamide, 4-(4-amino-3-chlorophenoxy)-3-chloro-7-methoxy-
|
樂(lè)伐替尼雜質(zhì)90
|
2023826-23-3
|
Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-[(1S,2R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]ethoxy]ethyl]-, bromide (1:1)
|
匹維溴銨雜質(zhì)3 匹維溴銨雜質(zhì)13
|
1970218-70-2
|
Cefoperazone EP Impurity A
|
頭孢哌酮雜質(zhì)A
|
73240-08-1
|
3-NITRO-PHTHALIC ACID 2-METHYL ESTER
|
阿齊沙坦雜質(zhì)C3-7
|
6744-85-0
|
2-Methyl-4-nitroimidazole
|
甲硝唑雜質(zhì)A
|
696-23-1
|
Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate
|
阿齊沙坦雜質(zhì)III-2
|
1403474-78-1
|
Methyl 2-[N-(tert-Butoxycarbonyl)-N-[(2'-cyanobiphenyl-4-yl)Methyl]aMino]-3-nitrobenzoate
|
阿齊沙坦雜質(zhì)SM01-9
|
139481-38-2
|
Metaxalone Related Compound
|
09022-C-IP-B
美他沙酮雜質(zhì)B
|
66766-07-2
|
1-[2-(ethylthio)ethyl]-2-methyl-5-nitro-1H-imidazole
|
1-[2-(乙硫基)乙基]-2-甲基-5-硝基-1H-咪唑
|
28795-33-7
|
Afatinib iMpurity
|
阿法替尼雜質(zhì)SM-1db
|
2831861-00-6
|
Veratric acid, 6,6′-azobis-
|
(E)-6,6’-(偶氮-1,2-二基)雙(3,4-二甲氧基苯甲酸)
|
860749-26-4
|
R-(E)]-alpha-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)benzenepropanol
|
2-[2-[3-(S)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-
羥基]丙基苯基]-2-丙醇(R-MTSM-1)
|
150026-75-8
|
Lecithin
|
L-alpha-卵膦脂
|
8002-43-5
|
4'-(Dibromomethyl)-[1,1'-Biphenyl]-2-Carbonitrile
|
阿齊沙坦雜質(zhì)SM02-4
|
209911-63-7
|
Ilaprazole Impurity 6
|
艾普拉唑雜質(zhì)6
|
2285346-42-9
|
Lithium bis(trimethylsilyl)amide
|
雙(三甲基硅烷基)氨基鋰, 1.0 M
solution in THF, MKSeal
Lithium bis(trimethylsilyl)amide, 1.0 M
solution in THF, MKSea
|
4039-32-1
|
Azilsartan pharMaceutical interMediate
|
阿齊沙坦雜質(zhì)C5
|
136304-78-4
|
Betamethasone Impurity 4
|
丙酸倍氯米松雜質(zhì)
|
114488-14-1
|
methyl 2-(azidocarbonyl)-3-nitrobenzoate
|
阿齊沙坦雜質(zhì)C3-3
|
856414-36-3
|
BENZOIC ACID, 2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-NITRO-METHYL ESTER
|
2-((叔丁氧羰基)氨基)-3-硝基苯甲酸甲酯
|
57113-90-3
|
2-(ETHYLSULFONYL)ETHANOL
|
2-(乙烷磺酰)乙醇
|
513-12-2
|
Ilaprazole Impurity 7
|
艾普拉唑雜質(zhì)7
|
2285346-41-8
|
4-(2-Cyanophenyl)benzyl alcohol
|
阿齊沙坦雜質(zhì)SM02-2
|
154709-19-0
|
Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
|
阿齊沙坦SM01
|
139481-44-0
|
Ilaprazole Impurity 5
|
艾普拉唑雜質(zhì)5
|
2285346-43-0
|
Methyl 2-amino-3-nitrobenzoate
|
2-氨基-3-硝基苯甲酸甲酯
|
57113-91-4
|
2-Dicyclohexylphosphino-2'-(N,N-dimethylamino)biphenyl
|
2-二環(huán)己膦基-2'-(N,N-二
甲胺)-聯(lián)苯
|
213697-53-1
|
1-[2-(Ethylthio)ethyl]-2-Methyl-4-nitroiMidazole
|
1-[2-(乙硫基)乙基]-2-甲基-4-硝基-1H-咪唑
|
13230-19-8
|
Azilsartan Impurity 29
|
阿齊沙坦雜質(zhì)SM01-1
|
139482-04-5
|
N-nitrosyl avanafil
|
N-亞硝基阿伐那非
|
|
1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid
|
阿齊沙坦雜質(zhì)1
|
1696392-11-6
|
(Z)-Ethyl-2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl) biphenyl-4-yl) Methyl)-3H-benzo[d] iMidazole-4-carboxylate
|
阿齊沙坦雜質(zhì)I-1
|
1397836-41-7
|
DIMETHYL 3-NITROPHTHALATE
|
3-硝基鄰苯二甲酸甲酯
|
13365-26-9
|
Clonixin
|
N6-(1-甲乙基)賴氨酸對(duì)照品 賴氨酸雜質(zhì)5
|
|
Ilaprazole Impurity 1
|
艾普拉唑雜質(zhì)1
|
2285346-38-3
|
Tris(dibenzylideneacetone)dipalladium
|
三(二亞芐基丙酮)二鈀(0),
|
51364-51-3
|
Piperazine, 1-(3-methoxyphenyl)-4-nitroso-
|
N-亞硝基烏拉地爾雜質(zhì)
|
2763779-41-3
|
Xanthine
|
Isoxanthine
|
69-89-6
|
Metronidazole EP Impurity D
|
甲硝唑雜質(zhì)D
|
5006-68-8
|
4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-
|
|
314771-88-5
|
Metronidazole EP Impurity F
|
甲硝唑雜質(zhì)F
|
16156-94-8
|
Posaconazole Impurity G
|
泊沙康唑雜質(zhì)G
|
1902954-05-5
|
3,5-Dichloro-4-hydroxybenzoic acid
|
3,5-二氯-4-羥基苯甲酸
|
3336-41-2
|
Minoxidil Impurity E
|
米諾地爾Minoxidil Impurity E
|
24867-26-3
|
TRIMETHYLENE OXIDE
|
|
503-30-0
|
Calcipotriol Impurity G
Chemical Name: 24,24`-oxybis[(5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta-diol]
|
卡泊三醇雜質(zhì)G
|
|
1,4-Benzenediol, 2-(4-hydroxyphenoxy)- (9CI)
|
AP23505雜質(zhì)A
間苯三酚雜質(zhì)67 738614-23-8
|
738614-23-8
|
|
艾迪骨化醇雜質(zhì)AF-Z7
|
41461-13-6
|
Diphenhydramine Impurity
|
氯苯海拉明鹽酸鹽
|
18608-78-1
|
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl
|
達(dá)格列凈雜質(zhì)24
|
2176485-21-3
|
Mesalazine Impurity 23
|
水楊酸甲酯雜質(zhì)A-3
|
5794-62-7
|
Aniline-2-sulfonic acid
|
2-氨基苯磺酸
|
88-21-1
|
DIPHENHYDRAMINE N-OXIDE
|
苯海拉明N-氧化物
|
3922-74-5
|
N,N-Dimethyl-2-[phenyl(4-methylphenyl)methoxy]ethanamine
|
對(duì)甲基苯海拉明
|
19804-27-4
|
Desmethoxyacetyliopromid
|
碘普羅胺雜質(zhì)A
|
154361-51-0
|
N-Nitroso-bisoprolol
|
N-亞硝基比索洛爾
|
2820170-76-9
|
4-nitrosomethylaminopyridine
|
N-甲基-N-(吡啶-4-基)亞硝酰胺
|
16219-99-1
|
N-(p-Aminobenzoyl)glutamic acid
|
|
4271-30-1
|
Ethinylestradio Impurity
|
炔雌醇雜質(zhì)B
|
1231-96-5
|
|
艾迪骨化醇雜質(zhì)AF105-Z2
(EP雜質(zhì)C)
|
82266-85-1
|
Brexpiprazole sulfoxide impurity
|
布瑞哌唑雜質(zhì)
布瑞哌唑
亞砜
|
1191900-51-2
|
Calcipotriol Impurity B
|
卡泊三醇雜質(zhì)B
|
2948288-30-8
|
4-(2,3-DIMETHYL-BENZYL)-1H-IMIDAZOLE
|
右美托咪定雜質(zhì) INT3-02
4-(2,3-二甲基芐基)-1H-咪唑
|
76631-46-4
|
Eperisone Impurity
|
乙哌立松雜質(zhì)1-(3,5-二乙基苯基)丙-1-酮對(duì)照品1806363-55-2
|
1806363-55-2
|
INDEX NAME NOT YET ASSIGNED
|
苯甲酸阿格列汀雜質(zhì)F
C,N-二芐基化合物
|
2716884-59-0
|
Eperisone Impurity
|
2'-乙基-2-甲基-3-哌啶苯丙酮鹽酸鹽
|
2608845-70-9
|
Brivudine Impurity
|
溴夫定氯化雜質(zhì)IP2
貨號(hào):BLD-XFD-17
|
74131-08-1
|
Ethinylestradiol Impurity
|
炔雌醇雜質(zhì)E
|
27521-34-2
|
17-Hydroxy-1a,2a-methylenepregna-4,6-diene-3,20-dione acetate
|
炔雌醇雜質(zhì)A
|
2701-50-0
|
Sevelamer carbonate
|
|
845273-93-0
|
Metronidazole EP impurity C
|
甲硝唑雜質(zhì)C
|
5006-69-9
|
3-(benzyhdryloxy) propane-1,2-diol
|
苯海拉明 3-(芐基乙氧基)丙烷-1,2-二醇
|
19574-66-4
|
Calcipotriol Impurity D
|
卡泊三醇雜質(zhì)
|
112827-99-3
|
Afatinib iMpurity
|
阿法替尼雜質(zhì)GLT-D
|
1680184-59-1
|
methyl sulfamate
|
氨基磺酸甲酯
|
55665-95-7
|
Tetrabutylammonium bromide
|
Sildenafil Impurity 14
|
1643-19-2
|